List of Khapzory drug patents

Khapzory is owned by Acrotech Biopharma.

Khapzory contains Levoleucovorin.

Khapzory has a total of 1 drug patent out of which 0 drug patents have expired.

Khapzory was authorised for market use on 19 October, 2018.

Khapzory is available in powder;intravenous dosage forms.

The generics of Khapzory are possible to be released after 25 March, 2039.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11541012 ACROTECH BIOPHARMA Compositions comprising disodium levofolinate
Mar, 2039

(15 years from now)

Do you want to check out KHAPZORY patents from before 2022?

Drugs and Companies using LEVOLEUCOVORIN ingredient

Market Authorisation Date: 19 October, 2018

Treatment: NA


More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic